Skip to nav Skip to content

News Releases and Statements

HPV Vaccination Rates Remain Critically Low Among Younger U.S. Adolescents

Despite national recommendations, only about 16 percent of U.S. adolescents have been fully vaccinated against human papillomavirus (HPV) by the time they turn 13, a JID study finds.

IDSA and HIVMA Letter to Secretary Alex Azar on Fetal Tissue Research

IDSA and HIVMA wrote to the U.S. Secretary for Health and Human Services Alex Azar, II to express concerns regarding the negative impact the review of fetal tissue research alternatives is having on HIV and infectious diseases research studies planned or underway.

Cancer Patients Face Higher Shingles Risk, New Vaccines Hold Promise for Prevention

People newly diagnosed with cancer, particularly blood cancers, and those on chemotherapy have a greater risk of developing shingles, a new JID study finds.

WHO/CDC Report on Global Measles Shows Toll of Vaccine Gaps

New report documents a steep climb in measles cases with severe outbreaks worldwide linked to vaccine coverage gaps indicates stalled momentum in efforts to control a preventable and deadly disease.

Climate Change Report Demands Public Health, Research Investments

Findings in the fourth federal National Climate Assessment highlight immediate threats and urgent challenges the incoming Congress must take on to confront climate change and its impacts on public health.

New Estimate of Annual Deaths Caused by Treatment Resistant Infections Highlights Gaps in Research, Stewardship, Surveillance

The Journal of Infection Control and Hospital Epidemiology estimates about 162,044 people die annually from multi-drug resistant infections in the US, stressing the immediate need for strengthened research and efforts.

Congress Recognizes Value of PEPFAR with Reauthorization; Funding Increases will be Critical

The Senate's approval reauthorizing PEPFAR acknowledges the program's role in reversing the trajectory of the AIDS pandemic and boosting responses against ID worldwide.

JID Study Sheds Light on Norovirus Outbreaks, May Help Efforts to Develop Vaccine

Outbreaks of norovirus in health care settings and those caused by a particular genotype of the virus are more likely to make people seriously ill, according to a new analysis.

ID Specialist Input Improves Outcomes for Outpatient Parenteral Antimicrobial Therapy: New IDSA Guidelines

Before patients receive intravenous (IV) antimicrobial infusion therapy outside of the hospital – whether at home, a doctor’s office or a skilled nursing facility – an infectious diseases (ID) specialist should review the order to ensure the most appropriate treatment, suggest updated guidelines released by the Infectious Diseases Society of America (IDSA).

Antibiotic-focused Pharmaceutical Company Cuts Highlight Vulnerability of Drug Development Pipeline

News of continued cutbacks at one of what is already a limited number of companies conducting antibiotic research and development threatens access to a critical medicine and further validates a critical need for government-led incentives that both reward and support work towards a robust, renewable antibiotic supply.

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.